tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Mohan Naidu, 82 are a BUY (100%).
Analyst Mohan Naidu, carries an average stock price target met ratio of 63.48% that have a potential upside of 22.94% achieved within 516 days. Previously, Mohan Naidu worked at OPPENHEIMER.
Mohan Naidu’s has documented 166 price targets and ratings displayed on 16 stocks. The coverage was on Healthcare, Technology, Financial Services, Industrials, Consumer Cyclical sectors.
Most recent stock forecast was given on EVH, Evolent Health at 12-Nov-2025.
Analyst best performing recommendations are on TRHC (TABULA RASA HEALTHCARE).
The best stock recommendation documented was for OMCL (OMNICELL) at 10/26/2018. The price target of $73 was fulfilled within 12 days with a profit of $8.5 (13.18%) receiving and performance score of 10.98.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 11-Sep-2019
$142
$49.39 (53.33%)
$128
1 months 14 days ago
(31-Aug-2026)
21/25 (84%)
$45.46 (47.09%)
178
Buy Since 31-Dec-2023
$115
$22.39 (24.18%)
$115
1 months 17 days ago
(28-Aug-2026)
3/9 (33.33%)
$18.63 (19.33%)
425
Buy Since 29-May-2026
$108
$15.39 (16.62%)
$108
4 months 12 days ago
(03-Jun-2026)
0/2 (0%)
$22.79 (26.75%)
Buy Since 04-Apr-2024
$111
$18.39 (19.86%)
$122
4 months 14 days ago
(01-Jun-2026)
5/8 (62.5%)
$20.36 (22.46%)
146
Buy Since 01-Jul-2021
$125
$32.39 (34.97%)
$125
4 months 19 days ago
(26-May-2026)
10/13 (76.92%)
$37.75 (43.27%)
318
